Pharma Mar SA (ES:PHM) has released an update.
Pharma Mar S.A. has successfully completed its share buyback program ahead of schedule, reaching the maximum allocated budget of €5 million. A total of 132,679 shares were purchased, amounting to 0.72% of the company’s share capital, with the intent to cancel these shares and reduce share capital. The program’s conclusion also marks the resumption of regulated operations under a liquidity contract with JB CAPITAL MARKETS from October 1, 2024.
For further insights into ES:PHM stock, check out TipRanks’ Stock Analysis page.
